Abstract: The invention relates to a kit-in-part comprising of a composition for the use as a cleaning and treating of ears of a companion animal and suitable packaging material, wherein the kit-in part additionally consists of components selected from the group of a pharmaceutical composition for use in the treatment of otitis externa, application and dosage information, cannules, cotton swabs, gauzes and information about the cleaning and maintenance ears of a companion animal.

Abstract: The invention relates to a composition containing cetrimide suitable for cleaning inflamed or non-inflamed ears of animals, preferably of companion animals such as dogs and cats. The composition further comprises one or more carriers, such as for example wetting agents and humectants.

Abstract: An inhaler for the propellant-free nebulization of a medicament preparation produces a low speed aerosol. The inhaler is combined with an add-on device for intermediate storage of the aerosol produced. The inhaler has a tensioning device for the one-handed tensioning of a drive spring and release thereof. The inhaler is provided with a dispensing device for large animals.

Abstract: The invention relates to a kit-in-part comprising of a composition for the use as a cleaning and treating of ears of a companion animal and suitable packaging material, wherein the kit-in part additionally consists of components selected from the group of a pharmaceutical composition for use in the treatment of otitis externa, application and dosage information, cannules, cotton swabs, gauzes and information about the cleaning and maintenance ears of a companion animal.

Abstract: The invention relates to a composition containing cetrimide suitable for cleaning inflamed or non-inflamed ears of animals, preferably of companion animals such as dogs and cats. The composition further comprises one or more carriers, such as for example wetting agents and humectants.

Abstract: The present invention relates to a proton pump inhibitor or a pharmaceutically acceptable salt thereof for the treatment of skin diseases in canine patients. The invention also relates to improving the quality of life, improving the general health condition as well as preventing secondary infections in canine patients suffering from skin diseases. Moreover, the present invention also relates to a pharmaceutical composition for topical administration, preferably for use in a method of treating skin diseases and/or improving the general health condition in canine patients, wherein such pharmaceutical formulation comprises a proton pump inhibitor or a pharmaceutically acceptable salt thereof and one or more excipients.

Abstract: An inhaler for the propellant-free nebulization of a medicament preparation produces a low speed aerosol. The inhaler is combined with an add-on device for intermediate storage of the aerosol produced. The inhaler has a tensioning device for the one-handed tensioning of a drive spring and release thereof. The inhaler is provided with a dispensing device for large animals.

Abstract: The present invention relates to antigenic preparations comprising polysaccharides and/or glycopeptides preparable from keratinophilic fungi as well as yeasts, process for the preparation of these antigenic preparations, their use as pharmaceutical substances as well as their use as vaccines, including but not limited to, the prophylaxis and treatment of allergy, as well as for modulating the immune response.

Abstract: The present invention relates to antigenic preparations comprising polysaccharides and/or glycopeptides preparable from keratinophilic fungi as well as yeasts, process for the preparation of these antigenic preparations, their use as pharmaceutical substances as well as their use as vaccines, including but not limited to, the prophylaxis and treatment of allergy, as well as for modulating the immune response.

Abstract: The present invention relates to antigenic preparations comprising polysaccharides and/or glycopeptides preparable from keratinophilic fungi as well as yeasts, processes for the preparation of these antigenic preparations, their use as pharmaceutical substances as well as their use as vaccines, including but not limited to, the prophylaxis and treatment of allergy, as well as for modulating the immune response.